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http://www.molecularbrain.com/content/7/1/10RESEARCH Open AccessVps35 haploinsufficiency results in degenerative-
like deficit in mouse retinal ganglion neurons and
impairment of optic nerve injury-induced gliosis
Wei Liu1,2, Fu-Lei Tang2,3, Joanna Erion2, Hang Xiao4, Jian Ye1* and Wen-Cheng Xiong2,3*Abstract
VPS35 (vacuolar protein sorting 35) is a major component of retromer that selectively promotes endosome-to-Golgi
retrieval of transmembrane proteins. Dysfunction of retromer is a risk factor for the pathogenesis of Parkinson’s
disease (PD) and Alzheimer’s disease (AD), both neuro-degeneration disorders. However, VPS35/retromer’s function
in retina or the contribution of Vps35-deficiency to retinal neuro-degenerative disorders has not been investigated.
Here we provide evidence for a role of VPS35 in mouse retinal ganglion cell (RGC) survival and regeneration. VPS35
is selectively expressed in developing mouse RGCs. RGCs from young adult Vps35 heterozygotes (Vps35+/m) show
degenerative-like features, such as dystrophic dendrites, reduced axon fibers, and increased TUNEL labeled RGCs.
Additionally, gliosis in the optic nerve is transiently elevated in neonatal, but reduced in aged Vps35+/m mice. Optic
nerve injury-induced gliosis is also attenuated in Vps35+/m mice. These results suggest that Vps35 is necessary for
mouse RGC survival and regeneration, and Vps35-deficiency may contribute to the pathogenesis of retinal ganglion
neuro-degeneration, a critical pathology leading to the blindness of many retinal degenerative disorders.
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Retromer is essential for selective retrieval of transmem-
brane proteins from endosomes to trans-Golgi network
[1-3]. Retromer contains two sub-protein complexes: the
cargo-selective complex and membrane deformation com-
plex [2,4]. VPS35 is the key component of the cargo-
selective complex, a trimer of VPS proteins VPS35, VPS29,
and VPS26. Dysfunction of VPS35/retromer is a risk factor
for neuro-degenerative disorders, including Parkison’s dis-
ease (PD) and Alzheimer’s disease (AD) [5-9]. Mutations
in Vps35 gene is identified in patients of late-onset PD
[5,6]. The retromer complex (e.g., Vps35 and Vps26) is de-
creased in the postmortem hippocampus of AD patients
[7]. In Vps35 or Vps26 deficient animals, the major culprit
of AD, β-amyloid (Aβ), is increased in the hippocampus
[7,9]. In addition, Vps35 haploinsufficiency in Tg2576* Correspondence: yejian1979@163.com; wxiong@gru.edu
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unless otherwise stated.mouse model of AD enhances Aβ-associated neuropathol-
ogy [9]. Furthermore, using in utero electroporation, sup-
pression of Vps35 expression in embryonic hippocampal
neurons results in “degenerative-like” phenotypes [10].
These observations thus suggest a critical role for VPS35/
retromer in preventing neuro-degeneration.
Retinal ganglion cells (RGCs), important neurons in
the retina, receive visual information from photorecep-
tors via two intermediate neurons (bipolar and amacrine
cells) and deliver the signal via their axons. RGC’s axons
form nerve fibers, extend into the optic nerve through
optic disc, further form the optic chiasm and optic tract,
and finally transmit visual information from the eye to the
brain. Dysfunction of RGCs or degeneration of RGCs is a
major pathology detected in several retinal disorders, in-
cluding glaucoma [11,12] and age-related macular degen-
eration(AMD) [12,13], which is a main reason leading to
irreversible blindness.
Although dysfunction of Vps35 is implicated in the
pathogenesis of AD and PD, its function in the retina is
largely unknown. We thus asked: where in the retina
Vps35 is expressed? Does loss of Vps35 contribute toThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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light on these questions by demonstrating Vps35 expres-
sion selectively in mouse RGCs. RGCs in Vps35 heterozy-
gote mice (named vps35+/m) exhibit degenerative-like
morphology, such as disturbed dendritic processes, reduced
axonal fibers, and increased RGC apoptosis. In addition,
Vps35+/m mice show impairment in optic nerve injury-
induced gliosis, implicating Vps35 in regulating optic nerve
regeneration.
Results
VPS35 expression in developing mouse RGCs, including
melanopsin positive ipRGCs
To investigate the potential role of VPS35 in retina, we first
examined vps35’s expression in mouse retina by taking ad-
vantage of vps35+/m mice, in which LacZ gene is knockedFigure 1 Vps35 expression in developing mouse retinas. (A) X-gal stain
mice at indicated ages. Scale bar, 200 μm. (B) The high magnification of X-ga
layer; INL: inner nuclear layer; OPL: outer plexiform layer; ONL: outer nuclear la
to GCL, a few LacZ positive cells were detected in INL indicated by arrow hea
from vps35+/+ and +/m at indicated ages. (D) Quantification analysis of percen
levels in retina from indicated age-groups of vps35+/+ and +/m mice. In (D-E),in the intron of vps35 gene, thus, the LacZ activity, under
the control of vps35 promoter, can be used as a reporter
for vps35’s expression [9,10,14]. The LacZ activity was
detected in developing mouse retinas from embryonic
12.5 to all the ages examined (Figure 1A and data not
shown). Interestingly, this LacZ activity was mainly distrib-
uted in the ganglion cell layer (GCL) of vps35+/m retinas
(Figure 1A). Higher power imaging analysis showed few
X-gal (ß-galactosidase) positive cells in the inner plexiform
(IPL) and upper inner nuclear (INL) layers, in addition to
GCL (Figure 1B). Note that not all of the cells in GCL were
LacZ positive (Figure 1B), and the ratio of LacZ positive
cells over total cells in GCL was around 30%, which was
reduced in aged retina (Figures 1A-D). These results sug-
gest that vps35 is mainly expressed in developing mouse
RGCs, and may be decreased during aging.ing (Blue color) showed lacZ gene expression in the retina of vps35+/m
l staining images was shown. GCL: ganglion cell layer; IPL: inner plexiform
yer; OS: outer segment; IS, inner segment. Scale bar, 50 μm. In addition
ds. (C) Western blot analysis of VPS35 expression in retina homogenates
tage of LacZ positive cells. (E) Quantification analysis of VPS35 protein
mean+/-SEM (n = 5) were presented.
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blot analysis. Consistently, An age-dependent reduction
of ß-galactosidase protein was observed in vps35+/m ret-
inas (Figures 1C-D). However, using anti-VPS35 anti-
body, the VPS35 protein levels were comparable among
different aged vps35+/+ retinas (Figures 1C and E). ~50%
reductions of Vps35 proteins were detected in young
(P1 to P60), but not aged (P90 to P180), Vps35+/m
retinas (Figures 1C and E), implicating a compensatory
effect in aged mutant mice. The differential results by
anti-ß-galactosidase and anti-VPS35 antibodies may result
from an age-dependent down-regulation of vps35’s tran-
scriptional expression (viewed by its LacZ reporter) or
ß-galactosidase protein stability, but not VPS35 protein.
To distinguish these possibilities, we examined vps35’s
transcripts from different aged Vps35+/+ and +/m retinas
by real time PCR (RT-PCR) analysis. Vps35’s mRNAs
appeared to be unchanged among various aged Vps35+/+
retinas, but decreased in Vps35+/m controls (Additional
file 1: Figure S1A). This result demonstrates the specifi-
city of the analysis and excludes the possibility for age-
dependent inhibition of vps35’s transcription. In line
with this view, little change was observed for the LacZFigure 2 VPS35 expression in mouse RGCs. Co-immunostaining analysis
mouse retinas using indicated antibodies. GCL, ganglion cell layer; NL, neu
outer plexiform layer; ONL, outer nuclear layer; OS, outer segment; IS, inner
images of the marked squares. Scale bar, 50 μm.transcripts detected in various aged Vps35+/m retinas, but
not in Vps35+/+ controls (Additional file 1: Figure S1B).
Taken together, these results suggest that Vps35 appears
to be stably expressed in mouse retina throughout devel-
opment, and the reduced LacZ staining/protein level in
aged mutant retina may be due to an-age dependent in-
stability of the LacZ protein. The stable VPS35 expression
in different aged retina GCL was further supported by
immunostaining analysis (Additional file 1: Figure S1C).
Note that vps35+/m retina (particularly at neonatal age)
showed ~50% reduction of VPS35 protein (Figures 1C, E),
demonstrating the antibody specificity. VPS26, another
component of retromer, was also decreased in vps35+/m
retina (Figure 1C). These results thus suggested that the
retromer complex is stably expressed in developing
mouse retina, which is mainly distributed in the ret-
inal GCL and lost in vps35+/m mice.
Retinal ganglion cells (RGCs) are largely distributed in
the GCL. We thus examined if VPS35 is expressed in
RGCs by co-immunofluorescence staining analysis using
anti-VPS35 or anti-β-gal antibodies in vps35+/+ or +/m
retinas. As shown in Figure 2A, VPS35 was largely co-
distributed with Tuj1, which recognizes neuronal classwas carried out in cross sections from P30 Vps35+/+ (A) and +/m (B-C)
roblast layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL,
segment. Arrows indicate co-localization signals. Inserts are amplified
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tal cells (marked by calbindin) and photoreceptor cells (by
rhodopsin), but weakly detected in amacrine cells (viewed
by calretinin) and glial cells (by GFAP) (Figures 2A-B).
These results thus provide evidence for the selective ex-
pression of VPS35 in mouse RGCs.
Note that a few β-gal positive cells were also distrib-
uted in IPL (inner plexiform layer), in addition to GCL
layer (Figure 1B). Such a distribution pattern is similar
to that of M1 type of ipRGCs (intrinsically photo-
sensitive retinal ganglion cells) that express melanopsin
[15,16]. We thus examined if Vps35 is co-distributed with
melanopsin in ipRGCs. Indeed, fractions, but not all,
of β-Gal positive cells were also melanopsin positive
(Figure 2C). Taken together, these results suggested that
VPS35 is expressed in developing mouse RGCs, including
ipRGCs.
Degenerative-like deficit in vps35+/m RGCs
Next we asked whether VPS35 plays a role in RGC devel-
opment and survival. RGC starts to develop around E10.5
and finished its development in neonatal age [17]. We car-
ried out immunostaining analysis of P1 flat-mounted eye
disc using antibodies against neurofilament or Tuj1, which
recognize RGCs’ soma, axons, and dendrites (by Tuj1). A
normal distributed RGC neuronal somas and axonal fi-
bers in Vps35+/m retina were observed (Additional file 2:
Figure S2), suggesting little, if there is any, role of VPS35
in RGC development.
We then examined RGCs in both flat-mounted and cross-
sectioned retina derived from P30 vps35+/+ and +/m mice by
immunostaining analysis of neurofilament. Whereas the
numbers and distribution of RGC somas appeared to be
normal in vps35+/m retina, RGC nerve fibers labeled by
neurofilament were reduced in vps35+/m retinas as com-
pared to that in vps35+/+ controls (Figures 3A-E), impli-
cating axonal deficit of RGCs in vps35 mutant retina.
Being consistent, immunostaining analysis using anti-Tuj1
antibody also showed reduced Tuj1+ RGC axons, but not
somas, in the mutant retinas (Figures 3C-E). These alter-
ations in vps35+/- retina resembled to that of dystrophic
RGC axons.
We further examined RGC dendritites in cross-sectioned
retina from P30 vps35+/+ and +/m mice. Tuj1-labeled RGC
dendritic processes appeared to be normal in P2 vps35+/m
retina (Figure 4A). At age of P20, RGC dendrites were ob-
viously disturbed in the IPL of vps35+/m retina with a re-
duced Tuj1 staining signal (Figures 4A-B). However,
western blot analysis using whole retina homogenates
showed no obvious difference in Tuj1 protein levels be-
tween vps35+/+ and +/m mice (Figure 4C). This may be
due to the large amounts of Tuj1 proteins distributed in
the soma and the soma density unchanged or slightly in-
creased in the mutant as compared to that of wild typecontrols (Figures 3C-E). The over-all retina morphology,
revealed by H & E staining analysis, appeared to be nor-
mal in vps35+/m retina as compared to that of vps35+/+
controls (Additional file 3: Figure S3). Taken together,
these results revealed axonal and dendritic degenerative-
like deficits in RGCs, but not in other neurons, in vps35
mutant retina.
We then asked if VPS35 plays a role in mouse RGC
survival. TUNEL assay, which label DNA damaged cells,
was carried out in vps35+/+ and +/m retinas. Remarkably,
increased TUNEL positive cells, particularly in the RGC
layer of both P7 and P30 vps35+/m retina, were detected
as compared to that of same age groups of vps35+/+ con-
trols (Figure 5). Thus, these results support the view for
a critical role of VPS35 in suppressing developing RGC
degeneration.
Reduced optic nerve injury-induced gliosis in neonatal
Vps35+/m mice
Optic nerves are assembled by RGC axonal fibers and glial
cells, such as oligodendricytes, astrocytes, and microglia
[18]. To examine whether optic nerves are altered in
vps35+/m mice, we first examined Vps35’s expression
in optic nerve homogenates from various aged vps35+/+
and +/m mice. Vps35 protein levels were high in neonatal
age (P15 and P30), but reduced in aged vps35+/+ mice
(Figure 6A), in contrast from that in mouse retinas
(Figure 1C). In agreement with the data from aged ret-
inas, Vps35 protein levels were only decreased to ~50%
in young age (P15 to P90), but not aged (e.g., P180),
optic nerves (Figure 6A). Interestingly, increased GFAP
(a marker for astrocytes) and MBP (myelin binding pro-
tein which marks oligodendricytes) levels were increased
in neonatal, but decreased in aged (e.g., P90 and P180),
vps35+/m optic nerves (Figure 6A). We thus further exam-
ined optic nerve phenotype in P30 vps35+/+ and +/m mice
by immunostaining analysis using antibodies against Tuj1
(to label RGC axons), GFAP (to mark astrocytes), MBP
(to view oligodendricytes), and IBA-1 (to stain microglia).
RGC axons didn’t show obvious difference between P30
vps35+/+ and +/m optic nerves, based on immuno-
staining and Western blot analyses using anti-Tuj1
antibodies (data not shown). Oligodendricytes labeled
by anti-MBP antibody were absent in the retina and
optic nerve head, but present posterior to the lamina
cribrosa-like region in both vps35+/+ and +/m optic
nerves (Figure 6C). In contrast, astrocytes marked by
GFAP were present in the retina and optic nerve head
(Figure 6C). In agreement with data from Western blot
analysis, Glial cells labeled by GFAP, MBP, and IBA-1
antibodies were all slightly increased in P30 vps35+/m
optic nerves (Figures 6C-D). These results thus suggest an
age-dependent alteration of gliosis in vps35+/m mutant
optic nerves.
Figure 3 Reduced RGC axon fibers in P30 vps35+/m retinas. (A-B) Immunostaining analysis using anti-neurofilament antibodies of flat-mounted
retinas (A) and cross sections (B) from P30 Vps35+/+ and +/m mice. In A, the bottom two panels are amplified images from the marked squares in
upper panel. OD: optic disc; NF: nerve fiber. (C) Immunostaining analysis using anti-Tuj1antibodies of flat-mounted retinas from P30 Vps35+/+ and +/m
mice. Scale bars in A-C, 50 μm. (D) Quantification analysis of the ratio of nerve fibers verse RGC somas stained by anti-Tuj1. (E) Quantification analysis
of RGC soma density. In (D-E), mean +/- SEM (n = 5 retinas) were shown. *, P < 0.05.
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injury-induce gliosis, a critical process associated with
optic nerve regeneration [19]. Optic nerves were crushed
at the site close to the optic disc (Figure 6B). 3-days after
injury, mice were sacrificed and optic nerves were exam-
ined by immunostaining analysis. Upon nerve injury,
gliosis, viewed by anti-GFAP, MBP, and IBA1 antibodies,
was increased in vps35+/+ optic nerves (Figures 6C-D).
MBP-labeled oligodendritecytes appeared to be shifted
to the site of optic disc (Figures 6C-D). In contrast, the
nerve injury induced gliosis, marked by GFAP and IBA1
antibodies, was attenuated in vps35+/m mice (Figures 6C-D),
suggesting an impairment of optic nerve injury-induced
gliosis.Discussion and conclusions
VPS35 is a key element of retromer that is a heteropen-
tameric complex with a transmembrane protein sorting
function from the endosome to the trans-Golgi network
[1-3]. Dysfunction of VPS35/retromer is a risk factor for
a number of neurodegenerative disorders, including PD
and AD [5-9,20]. Given VPS35’s crucial function in sup-
pressing neuro-degeneration, we asked if it plays a role in
retinal neuron survival. Here, we presented several lines of
evidences for a critical role of VPS35 in mouse RGC sur-
vival. First, VPS35 is selectively expressed in developing
mouse RGCs. Second, vps35+/m retina show degenerative-
like RGCs, with disturbed RGC dendrites, reduced RGC
axon fibers, and increased apoptosis. Third, vps35+/m
Figure 4 (See legend on next page.)
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Figure 4 Disturbed RGC dendrites in P20 vps35+/m retinas. (A) Immunostaining analysis using anti-Tuj1 antibodies of cross-sections of retinas
from vps35+/+ and +/m mice at indicated ages. Inserts are amplified images of the marked squears. GCL, ganglion cell layer; NL, neuroblast layer;
IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; OS, outer segment; IS, inner segment.
Arrows indicate co-localization signals. Inserts are amplified images of the marked squares. Scale bar, 50 μm. (B) Quantification analysis of the
fluorescence intensity in RGC dendrites marked by anti-Tuj1. The values of mean +/- SEM (n = 5 retinas) were shown. *, P < 0.05. (C) Western blot
analysis of Tuj1 expression in retina homogenates from vps35+/+ and +/m at indicated ages.
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natal age, but reduced in aged mice. Finally, optic nerve
injury-induced gliosis is attenuated in vps35+/m mice.
Several characteristics of Vps35’s expression in mouse
retina are noted. It is selectively expressed in mouse RGCs.
This is based on in large the distribution of the LacZ re-
porter in the Vps35 gene. This view is also confirmed by
immunostaining analysis using anti-VPS35 antibody. The
LacZ reporter expression in RGCs is reduced during aging.
However, no obvious reduction in Vps35 protein levels
was detected by Western blot analysis of the retina homog-
enates. These results implicate that Vps35’s protein may be
very stable, but its transcript could be reduced during
aging. In addition, VPS35 is expressed in subset of RGCs,
including ipRGCs. However, the function of VPS35 in
ipRGCs remains to be further investigated.
The degenerative-like morphology of vps35+/- RGCs
may be largely caused by the reduced VPS35 expression
in RGCs. This view is in line with the observation of the
selective expression of VPS35 in developing RGCs. However,
we cannot exclude the possibility of cell non-autonomous
mechanisms, as Vps35 is also weakly expressed in glial
cells, such as astrocytes and microglia, and vps35+/m mice
show altered gliosis (Figure 6) and increased inflammation
[14]. The latter may contribute further RGC degeneration.
Gliosis, a nonspecific reactive change of glial cells in
response to damage to the neurons, involves the prolif-
eration of different types of glial cells, including astro-
cytes, microglia, and oligodendrocytes. Gliosis has both
beneficial and detrimental effects. Its beneficial effects
include neuroprotection, maintenance of the extracellu-
lar environment, seclusion of the injury site, and nerve
regeneration [21,22]. Its detrimental effects are restriction
of axon regeneration when there is glial scar formation.
Vps35+/m mice showed an-age dependent gliosis, detected
in neonatal, but not aged, mice. Such a transient gliosis
may be the consequences of the RGC degeneration. Inter-
estingly, optic nerve injury-induced gliosis was attenuated
in Vps35+/m mice, implicating that VPS35 may play a role
in nerve regeneration.
The retinal degeneration is a major pathology associ-
ated with glaucoma [11,12] and age-related macular de-
generation (AMD) [12,13]. It is of interest to note that
glaucoma or AMD is often associated with other neuro-
degenerative disorders, including AD and PD [12]. Mu-
tations in Vps35 gene are identified in late onset PDpatients [5,6]. Dysfunction of retromer is also believed to
be a risk factor for AD [7,9]. However, it remains un-
known if there is any mutation in vps35 gene or other ret-
romer component in patients with glaucoma or AMD.
Given the fact we demonstrate here that VPS35 regulates
RGC survival, plus the association of retinal RGC degen-
eration with neuro-degeneration, it is conceivable that
dysfunction of VPS35 or other retromer component may
contribute to the pathogenesis of glaucoma or AMD pa-
tients. Clearly, this requires further analysis of the putative
causative genes in glaucoma or AMD patients.
Methods
Animals and reagents
Vps35 mutant mice have been described previously
[9,10,14], which were backcrossed with C57BL/6 mice
for more than 10 generations. Mice were maintained on
a standard rodent diet. Vps35 mutations were confirmed
by genotyping using PCR and Western blot analysis. All
experimental procedures were approved by the Animal
Subjects Committee at the Georgia Regents University
according to US National Institutes of Health guidelines.
Rabbit polyclonal anti-VPS35 antibody was generated
using the antigen of GST-VPS35D1 fusion protein as de-
scribed previously [9,10,14]. Rabbit polyclonal antibodies, in-
cluding anti- ß-galactosidase (Cappel), anti-VPS26 (Abcam),
anti-calretinin (Swant), and anti-melanopsin (Advanced
Targeting Systems) antibodies, were purchased. Mouse
monoclonal antibodies, including anti-neuronal class III
ß-Tubulin (Tuj1,Convance), anti-neurofilament (DSHB),
anti-calbindin D28k (Swant), anti-glial fibrillary acidic pro-
tein (GFAP, Chemicon), anti-rhodopsin (Abcam) and anti-
myelin basic protein (MBP, Chemicon) antibodies, were
also purchased. In addition, the chicken polyclonal anti-
ß-galactosidase antibody (Abcam) and goat polyclonal
anti-IBA1 antibody (Abcam) were used. Secondary anti-
bodies were purchased from Jackson Immuno Research
Laboratories, Inc. Other chemicals and reagents used in
this study were of analytical grade.
β-Gal detection, immunofluorescence staining, and
confocal imaging analysis
Vps35+/+ or +/m mice were sacrificed and the eyes were ex-
cised. For β-Gal detection, the eyes were immediately em-
bedded in OCT medium (Sakura Finetek, Torrance, CA),
and frozen at -80°C for 2h. 20 μm-thick sections were cut
Figure 5 Increased TUNEL positive RGCs in vps35+/m retinas. TUNEL staining analysis was carried out in cross-sections of retinas from P7
(A) and P30 (B) vps35+/+ and +/m mice . GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer;
ONL, outer nuclear layer. Scale bar, 50 μm. The TUNEL+ cells in GCL were quantified and showed as mean +/- SEM (n = 3) in (C). *, P < 0.05.
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Figure 6 Impairment of optic nerve injury-induced gliosis in vps35+/m mice. (A) Western blot analysis of homogenates from vps35+/+
and +/m optic nerves at indicated ages using indicated antibodies. (B) Illustration of mouse optic nerve injury. P30 vps35+/+ and +/m optic nerves
were crushed as indicated. 3-days after injury, optic nerves were sectioned and subjected to immunostaining analysis. (C) Immunostaining analysis
of optic nerves using indicated antibodies. Injury sites were marked with yellow arrows. Scale bar, 50 μm. (D) Quantification analysis of data from
(C). Immunofluorescence intensity was normalized by the uninjured vps35+/+ controls. The values of mean +/- SEM (n = 3) were shown.
*, P < 0.05, significance difference from the vps35+/+ control.
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For immunofluorescence staining, after eyes excised, the
corneas were removed, eye cups were fixed in 4% parafor-
maldehyde in 0.1 M PBS at 4°C for 24 h. Lenses were then
removed, the retina to be flat-mounted were dissected
from eye cups and processed in 1.5ml microfuge tubes.
Eye cups for cross sectioning were cryo-protected with
30% sucrose in PBS at 4°C for 24 h, embedded in OCT
medium (Sakura Finetek, Torrance, CA), frozen, sectioned
at 12 μm-thickness, and mounted onto Super-Frost Plus
slides.
β-Gal activity was detected as described previously
[9,10,14,23,24]. In brief, frozen eye sections derived from
Vps35+/+ and Vps35+/m mice were fixed with 0.5% glutar-
aldehyde and incubated with X-gal solution (2 mM MgCl2,
5 mM potassium ferricyanide, 5 mM potassium ferro-
cyanide, and 0.1% X-gal) in the dark at 37°C for 12 h.
The slides were washed, mounted in permount (Thermo
Fisher Scientific), and imaged using deconvolution digital
microscope (Axioplan 2; Carl Zeiss) with high sensitivity
camera (AxioCam; Carl Zeiss) and equipped with a plan-
neofluar 5× and plan-neofluar 10×/0.30 NA objective lens.For immunofluorescence staining analysis, flat mounts
or cross-sections were post-fixed with 4% PFA at room
temperature for 15 min, permeabilized with 0.3% Triton
X-100 at room temperature for 20 min, and blocked
with 10% horse serum and 5% BSA at room temperature
for 2 h. Flat mounts or sections were incubated for 24 h
at 4°C in primary antibodies. Antibodies used were
rabbit polyclonal anti-VPS35 (1:1,000), mouse monoclonal
anti-Tuj1 (Convance, 1:1,000), mouse monoclonal anti-
neurofilament (DSHB, 1:1,000), rabbit polyclonal anti-
calretinin (Swant, 1:500), rabbit polyclonal anti-melanopsin
(Advanced Targeting Systems, 1:5,000), mouse monoclonal
anti-calbindin D28k (Swant, 1:2,000), mouse monoclonal
anti-GFAP (Chemicon, 1:1,000), mouse monoclonal anti-
Rhodopsin (Abcam, 1:500), mouse monoclonal anti-MBP
(Chemicon, 1:500), goat polyclonal anti-IBA1 antibody
(Abcam, 1:500) and chicken polyclonal anti-ß-galactosi-
dase (Abcam, 1:1,000). Flat mounts or sections were incu-
bated with appropriate fluorescent secondary antibodies
at room temperature for 2 h, then incubated with Topro3
(1:5,000) at room temperature for 10 min. Slides were
mounted using VECTASHIELD mounting medium. Confocal
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For fluorescent quantification, morphometric measurements
of images were performed using Image- pro plus software
(Media Cybernetics).
Tissue lysis and western blotting
Retina and optic nerve tissues were lysed in lysis buffer
(50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40,
0.5% Triton X-100, 1 mM phenylmethylsulfonyl fluoride
(PMSF), 1 mM EDTA, 5 mM sodium fluoride, 2 mM so-
dium orthovanadate and protease inhibitors) 15 minutes
at 4°C and centrifuged at 14,000 × g, protein concentra-
tion was determined by BCA protein assay kit (Thermo).
Resulting supernatants separated by SDS-PAGE in 8%–
12% gradient gels. Electroblotting was at 4°C for 2 hours
(100V, 400 mA). Membranes were blocked in 10% silk
milk at room temperature for 1h. Primary antibody incu-
bation was overnight at 4°C. After 3× washes with TBST
(Tris-Buffered Saline and Tween 20), membranes were incu-
bated in secondary antibodies for 1 h at room temperature.
Primary antibodies included rabbit polyclonal anti-VPS35
(1:10,000), rabbit polyclonal anti-VPS26 (Abcam, 1:2,000),
rabbit polyclonal anti-ß-galactosidase (Cappel, 1:2,000),
mouse monoclonal anti-Tuj1 (Convance, 1:4,000), mouse
monoclonal anti-GFAP (Chemicon, 1:1,000) and mouse
monoclonal anti-MBP (Chemicon, 1:1,000). Secondary anti-
bodies (all 1:8,000 dilution; all Thermo) were anti-mouse
and anti-rabbit HRP. Band intensities were quantified
densitometrically and normalized to ß-actin. For semi-
quantitative analysis, protein bands detected by ECL were
scanned into Adobe Photoshop CS5 and analyzed using
ImageJ software (National Institutes of Health). Care was
taken during exposure of the ECL film to ensure that in-
tensity readouts were in a linear range of standard curve
blot detected by the same antibody.
Terminal deoxynucleotidyl transferase-mediated
biotinylated UTP nick end labeling (TUNEL)
Sections were processed for TUNEL as described above.
TUNEL assay was performed using the In Situ Cell Death
Detection Kit (Roche).
Optic nerve injury
Optic nerve injury was performed in Vps35+/+ and
Vps35 +/m mice at P30 as described previously [19]. Only
the left optic nerve was injured, the right optic nerve served
as negative control. Mice were anesthetized by intraperito-
neal injection of Ketamine and Xylazine (100 mg/kg and
20 mg/kg body weight). The incision was made in the
conjunctiva at the superior pole of the eye, then a blunt
dissection of the conjunctiva was made with forceps to-
wards the back of the eye to expose the retrobulbar
optic nerve. The optic nerve was crushed with forcep for
10 seconds at 1 mm behind the globe. After the surgery,tobramyclin ointment was applied to avoid infection and
the animal recovered on a warming pad. After 3 days,
mice were sacrificed, the eyes were excised, then removed
the optic nerves from the eye-balls. The optic nerves were
fixed in 4% paraformaldehyde in 0.1 M PBS at 4°C for
24 h and cryo-protected with 30% sucrose in PBS at 4°C
for 24 h, embedded in OCT medium(Sakura Finetek,
Torrance, CA), frozen, sectioned 12 μm-thickness, and
mounted onto Super-Frost Plus slides.
Statistical analysis
All data were expressed as means ± SEM. Three to five
mice per genotype per assay were used. Three to five posi-
tions were quantified for immunostaining analyses. The
significance level was set at P < 0.05, and the Student’s
t test was used.
Additional files
Additional file 1: Figure S1. Vps35 expression in various aged mouse
retinas. (A) Real time PCR analysis showed vps35’s expression in vps35+/+
mouse retinas at indicated ages, which was reduced in the same age-groups
of vps35+/m retinas. (B) Real time PCR analysis showed LacZ transcripts
only in vps35+/m, but not in vps35+/+, mouse retinas at indicated
ages, suggesting the specificity of the RT-PCR analysis. In (A-B), mean +/-
SEM (n = 3) were shown. (C) Immunostaining analysis using anti-VPS35
antibody showed Vps35’s distribution in GCL of Vps35+/+ mouse retina at
indicated ages, which was also reduced in Vps35+/m retinas, demonstrating
the antibody specificity. Scale bar, 100 μm.
Additional file 2: Figure S2. RGC axon fibers in P1 vps35+/m retinas.
(A) Immunostaining analysis using anti-neurofilament antibodies of
flat-mounted retinas from P1 Vps35+/+ and +/m mice. OD: optic disc;
NF: nerve fiber. Scale bars, 50 μm. (B) Quantification analysis of the ratio
of nerve fibers verse RGC somas stained by anti-neurofilament. The
mean +/- SEM ( n = 3) were presented.
Additional file 3: Figure S3. H & E staining analysis of retina
morphology in vps35+/+ and +/m mice at indicated ages. GCL, ganglion
cell layer; NL, neuroblast layer; IPL, inner plexiform layer; INL, inner
nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; OS,
outer segment; IS, inner segment. Scale bar, 50 μm.
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